FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
Jefferies raised its price target on Horizon Pharma (NASDAQ: HZNP) to $21.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report.
Including the upside from the Q3 results and expected shift in operating expenses from Q3 to Q4, Jefferies raised... More

